Center for Employment Opportunities Launches ‘More Than A Background’ Campaign to Raise Awareness of the Barriers People with Criminal Records Face in Obtaining Employment as a Result of Overreliance on Background Checks
#MoreThanABackground Launch Coincides with Start of ‘Second Chance Month’ NEW YORK, April 1, 2024 /PRNewswire/ — Today, the Center for Employment Opportunities (CEO), the nation’s largest reentry organization, launched ‘More Than a Background‘ (#MoreThanABackgroun
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Four potential near-term milestones, including data from two clinical trials, an NDA filing and an upcoming share dividend — 50% reduction in corporate overhead and 25% reduction in overall net loss in 2023, compared to 2024 with $0.20 per share improvement in negative earnings. Additions to w
Flash News: OKX to List Wormhole Protocol’s Native Token, Expanding Spot Trading Options
DUBAI, UAE, April 1, 2024 /PRNewswire/ — OKX, a leading crypto exchange and Web3 technology company, has issued updates for April 1, 2024. OKX to List Wormhole Protocol’s Native Token, Expanding Spot Trading Options OKX is pleased to announce that it will list Wormhole Protocol‘s
Castaway Cannabis Sets Sail in Delran, New Jersey by the Delaware River with Grand Opening of Nautical-Themed retail store.
DELRAN, N.J., April 1, 2024 /PRNewswire/ — Castaway Cannabis, a new and exciting cannabis retail store with a unique nautical theme, is thrilled to announce the grand opening of its flagship location in Delran, New Jersey. The recent official launch invited the community to set sail with Casta
Lutris Pharma Appoints Life Sciences and Pharmaceutical Entrepreneur Moshe “Mori” Arkin to Its Board of Directors
TEL AVIV, Israel, April 1, 2024 /PRNewswire/ — Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing dose limiting side effects, today announced the appointment Moshe “Mori” Arkin, a life sciences and pharmaceutical
BOARDWALKTECH SECURES $US4.0 MILLION LINE OF CREDIT FACILITY
Non-dilutive, ARR-based debt instrument for growth-stage purposes CUPERTINO, Calif., April 1, 2024 /PRNewswire/ – (TSXV: BWLK) (OTCQB: BWLKF) – Boardwalktech Software Corp (“Boardwalktech” or the “Company”), a leading digital ledger platform and enterprise softw
7-Eleven International Completes Acquisition of 7-Eleven Australia
7-Eleven International now operates 7-Eleven Australia convenience stores IRVING, Texas, April 1, 2024 /PRNewswire/ — 7-Eleven International LLC announced today the successful completion of its acquisition of 7-Eleven Australia convenience stores. The two companies agreed to the A$1.71 billion
Ionis to present at upcoming investor conferences
CARLSBAD, Calif., April 1, 2024 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will participate in fireside chats at the following investor conferences: 23rd Annual Needham Virtual Healthcare Conference on Monday, April 8, 20242024 RBC Capital Markets
Koel USA Inc. Selects Univar Solutions to Represent Specialty Pigment and Dyes Portfolio
With the increased demand for beauty and personal care products, Univar Solutions strengthens its portfolio of cosmetic pigments to offer even more innovative color solutions for customers in the United States DOWNERS GROVE, Ill., April 1, 2024 /PRNewswire/ — Univar Solutions, LLC (Univar Solu
Ascend Wellness Holdings CEO, John Hartmann, Demonstrates Confidence in Company by Acquiring Stock
NEW YORK, April 1, 2024 /PRNewswire/ – Ascend Wellness Holdings, Inc. (“AWH” or the “Company”) (CSE: AAWH-U.CN) (OTCQX: AAWH), a multi-state, vertically integrated cannabis operator, proudly announces that its CEO, John Hartmann, has recently acquired 192,500 shares of
